A retrospective study on Escherichia coli bacteremia in immunocompromised patients: Microbiological features, clinical characteristics, and risk factors for shock and death
Open Access
- 8 April 2020
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (8), e23319
- https://doi.org/10.1002/jcla.23319
Abstract
Background To evaluate clinical features, bacterial characteristics, and risk factors for shock and mortality of immunocompromised patients with Escherichia coli bacteremia. Methods A nearly 6‐year retrospective study of E coli bacteremia in 188 immunocompromised patients at Xiangya Hospital was conducted. Demographic, clinical, and laboratory data were documented. Phylogenetic background and virulence factors of E coli isolates were detected by polymerase chain reaction. Risk factors for shock and mortality were also investigated. Results Of all 188 E coli isolates, most prevalent virulence factors were fimH (91.0%), followed by traT (68.6%) and iutA (67.0%), while papG allele I, gafD, and cdtB were not detected. Phylogenetic group D was dominant (42.0%) among all isolates, and group B2 accounted for 17.6%, while group A and B1 accounted for 28.2% and 12.2%, respectively. In univariate analysis, ibeA and cnf1 were associated with mortality, which were not found in multivariate regression analysis. 22.3% of patients suffered shock, and 30‐day mortality rate was 21.3%. MDR (HR 2.956; 95% CI, 1.091‐8.012) was the only risk factor for shock, while adult (HR 0.239; 95% CI, 0.108‐0.527) was a protective factor. Multivariate analysis revealed that shock (HR 4.268; 95% CI, 2.208‐8.248; P < .001) and Charlson index > 2 (HR 2.073; 95% CI, 1.087‐3.952; P = .027) were associated with fatal outcome. Conclusions Escherichia coli bacteremia was highly lethal in immunocompromised patients, and host‐related factors played major roles in poor prognosis, while bacterial determinants had little effect on outcome. This study also provided additional information about the virulence and phylogenetic group characteristics of E coli bacteremia.Keywords
Funding Information
- Central South University (2019zzts802)
- Natural Science Foundation of Hunan Province (2018JJ6058)
- National Natural Science Foundation of China (81702068)
This publication has 50 references indexed in Scilit:
- Assessing the diversity of the virulence potential ofEscherichia coli isolated from bacteremia in São Paulo, BrazilBrazilian Journal of Medical and Biological Research, 2013
- Outcome of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli: Impact of microbiological determinantsJournal of Infection, 2013
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology & Infection, 2012
- Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian regionClinical Microbiology & Infection, 2008
- Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsisClinical Microbiology & Infection, 2007
- Microbiological Findings in Febrile NeutropeniaArchives of Medical Research, 2000
- Prevalence of Virulence Genes and Clonality in Escherichia coli Strains That Cause Bacteremia in Cancer PatientsInfection and Immunity, 2000
- Proposal for a New Inclusive Designation for Extraintestinal Pathogenic Isolates ofEscherichia coli:ExPECThe Journal of Infectious Diseases, 2000
- Extended Virulence Genotypes ofEscherichia coliStrains from Patients with Urosepsis in Relation to Phylogeny and Host CompromiseThe Journal of Infectious Diseases, 2000
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994